class="knockout" style="margin-top: 0px;margin-bottom: 1px;font-size: 14px;line-height: 1.2;padding: 5px;padding-left: 20px;padding-right: 20px;font-weight: normal;">THANK YOU FOR SUBSCRIBING
The L7 mission is to revolutionize the scientific process by streamlining process and data management, thereby accelerating precision health across life sciences, healthcare, and food value-chains.
FREMONT, CA: L7 Informatics, a leader in enterprise-scale digital transformation and automation of scientific processes in the life sciences and healthcare domains, announced that it closed its Series B financing round. Previous investors supported the financing along with several new investors, including Phoenix Venture Partners.
"We are very excited to join the L7 mission. The company's Enterprise Science Platform has the core flexibility and breadth needed to advance healthcare and life sciences R&D and manufacturing into a new digital age," said Dr. Zach Jonasson, Managing Partner of Phoenix Venture Partners.
Proceeds from the financing will be used to accelerate the commercialization of L7's Enterprise Science Platform, an industry-leading software platform that simplifies data management, digitalizes and automates workflows in the therapeutics, diagnostics, medicine, research, and agrochemical industries, to enable breakthrough efficiencies, better compliance, reduced costs, and improved operational velocity.
CEO Dr. Vasu Rangadass stated, "We appreciate the shared commitment of our investors to L7's vision of digitalizing healthcare and life sciences R&D and manufacturing processes. This investment will enable us to continue expanding our product portfolio to support the growing demand for innovation in workflow and data management in life sciences."